-
JPMorgan Upgrades Alkermes As The Company Adds To Its Already Valuable Portfolio
Friday, October 21, 2016 - 2:38pm | 348A day after Alkermes Plc (NASDAQ: ALKS) revealed positive results from ALKS 5461 for major depressive disorder treatment, JPMorgan upgraded the shares from Neutral to an Overweight rating. The firm also boosted the target price from $51 to $78 on the company's shares, saying that the drug candidate...
-
This Hedge Fund Manager Spoke With Lumber Liquidators' Chairman -- Here's What He Thinks
Wednesday, March 11, 2015 - 6:11pm | 504As Lumber Liquidators Holdings Inc (NYSE: LL) slowly recuperates from the effects of the "60 Minutes" report, Lemelson Capital Management Chief Investment Officer Rev. Emmanuel Lemelson spoke with Founder and Chairman Tom Sullivan. Lemelson then shared his thoughts and conclusions with...